Spritz R A
Laboratory of Genetics, University ofWisconsin, 445 Henry Mall, Madison, WI 53706, USA.
Platelets. 1998;9(1):21-9. doi: 10.1080/09537109876960.
Hermansky-Pudlak syndrome(HPS) and Chediak-Higashi syndrome(CHS) are similar but distinct autosomal recessive genetic diseases in which a bleeding diathesis resulting from platelet storage pool deficiency is accompanied by deficient pigmentation of the skin and hair and various systemic abnormalities associated with defective lysosomal function. The diverse multi-systemic manifestations of HPS and CHS are associated with abnormalities of a number of different cytoplasmic organelles--platelet dense granules, melanosomes, lysosomes and various cytoplasmic secretory granules. Though rare, HPS and CHS probably represent just the first of what will eventually be a novel class of genetic disorders resulting from defective biogenesis, structure or function of these organelles. The genes responsible for HPS and CHS have recently been identified and are beginning to yield insights into the molecular genetics and cellular pathophysiology of these intriguing disorders.
赫尔曼斯基-普德拉克综合征(HPS)和切迪阿克-希加综合征(CHS)是相似但又有区别的常染色体隐性遗传病,其特征为血小板储存池缺乏导致的出血倾向,同时伴有皮肤和毛发色素沉着不足以及与溶酶体功能缺陷相关的各种全身异常。HPS和CHS多样的多系统表现与多种不同的细胞质细胞器异常有关,包括血小板致密颗粒、黑素小体、溶酶体和各种细胞质分泌颗粒。虽然罕见,但HPS和CHS可能仅仅是最终将成为由这些细胞器生物发生、结构或功能缺陷导致的新型遗传疾病中的首例。导致HPS和CHS的基因最近已被确定,并开始为这些有趣疾病的分子遗传学和细胞病理生理学提供见解。